Cubist Systematic Strategies’s AdaptHealth AHCO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-708,016
Closed -$8.15M 2900
2024
Q1
$8.15M Buy
708,016
+206,118
+41% +$1.75M 0.05% 651
2023
Q4
$3.66M Buy
501,898
+338,778
+208% +$2.67M 0.02% 1062
2023
Q3
$1.48M Buy
+163,120
New +$1.96M 0.01% 1587
2023
Q2
Sell
-16,378
Closed -$204K 3429
2023
Q1
$204K Sell
16,378
-73,574
-82% -$1.35M ﹤0.01% 3219
2022
Q4
$1.73M Buy
89,952
+10,186
+13% +$215K 0.01% 1971
2022
Q3
$1.5M Sell
79,766
-110,182
-58% -$2.26M 0.01% 2273
2022
Q2
$3.43M Buy
189,948
+93,893
+98% +$1.52M 0.02% 1335
2022
Q1
$1.54M Buy
96,055
+71,449
+290% +$1.28M 0.01% 1702
2021
Q4
$602K Sell
24,606
-536
-2% -$12.6K 0.01% 2312
2021
Q3
$586K Sell
25,142
-18,928
-43% -$458K 0.01% 1922
2021
Q2
$1.21M Buy
44,070
+33,918
+334% +$967K 0.01% 1429
2021
Q1
$373K Sell
10,152
-32,563
-76% -$1.15M ﹤0.01% 2125
2020
Q4
$1.6M Buy
+42,715
New +$1.32M 0.02% 1096

Other funds holding AHCO

Cubist Systematic Strategies's AHCO Position: Q2 2024 in Review

Cubist Systematic Strategies sold out of AdaptHealth (AHCO) in Q2 2024, closing a stake of 708,016 shares — an estimated $8.15M sold.

Cubist Systematic Strategies first reported a position in AHCO in Q4 2020 and held it in 13 quarters. The position peaked at $8.15M in Q1 2024. 207 funds tracked by Wall St. Rank hold AHCO as of Q2 2024.

  • Cubist Systematic Strategies reported no remaining AdaptHealth position as of Q2 2024 after selling out during the quarter.
  • Cubist Systematic Strategies sold 708,016 AdaptHealth shares in Q2 2024, an estimated $8.15M.
  • Cubist Systematic Strategies first reported a position in AdaptHealth in Q4 2020 and held it in 13 quarters.
  • Cubist Systematic Strategies's AdaptHealth position peaked at $8.15M in Q1 2024.
  • 207 funds tracked by Wall St. Rank held AdaptHealth as of Q2 2024.

Based on Cubist Systematic Strategies's 13F filing for Q2 2024, filed 14 Aug 2024.